GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 354.78
0.00 (0.00%)
At close: May 29, 2026
GlaxoSmithKline Pakistan Company Description
GlaxoSmithKline Pakistan Limited, a biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.
It offers products in the anti-infective, dermatology, respiratory, immunology and inflammation, oncology, infectious diseases, HIV, and vaccines therapy areas.
The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol, Shingrix, and Cutivate brands.
It also exports its products. The company was founded in 2001 and is headquartered in Karachi, Pakistan.
GlaxoSmithKline Pakistan Limited operates as a subsidiary of GSK plc.
GlaxoSmithKline Pakistan Limited
| Country | Pakistan |
| Founded | 2001 |
| Industry | Pharmaceuticals |
| Sector | Healthcare |
| Employees | 1,606 |
| CEO | Erum Rahim |
Contact Details
Address: 35, Dockyard Road Karachi, 74000 Pakistan | |
| Phone | 92 21 111 475 725 |
| Website | pk.gsk.com |
Stock Details
| Ticker Symbol | GLAXO |
| Exchange | Pakistan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PKR |
| ISIN Number | PK0001301016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Erum Rahim | Chief Executive Officer |
| Hasham Baber | Chief Financial Officer |